can you take retatrutide while breastfeeding Contraindications: Risks and Considerations for Patients Retatrutide Side Effects and Safety:

Each 3ml vial contains approximately 5mg BPC-157 and 10mg TB-500, pre-mixed at an optimal ratio by a licensed compounding pharmacy

Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription

Efficacy and safety of tongxinluo capsules combined with conventional therapy for acute myocardial infarction: a systematic review and meta-analysis

However, the timeline can vary depending on the individual, dosage, and intended use